RecruitingPhase 3NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Sponsor: GlaxoSmithKline
Moorestown, NJ · Sewell, NJ · +55 more sites
2 recruiting copd studies with a site in Sewell, NJ.
Sponsor: GlaxoSmithKline
Moorestown, NJ · Sewell, NJ · +55 more sites
Sponsor: AstraZeneca
Millville, NJ · Sewell, NJ · Toms River, NJ · +70 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.